Back to announcement
20260115_KLBF_Laporan Pengalihan Saham Hasil Buy Back_32020345.pdf
Other Text extracted KLBFSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page Nomor Surat 005/CSEC-KF/I-2026 Nama Perusahaan Kalbe Farma Tbk Kode Emiten KLBF Lampiran 1 Perihal Laporan Pengalihan Kembali Saham Hasil Buy Back Laporan Pelaksanaan Pengalihan Kembali Saham Hasil Buy Back Perseroan melaporkan pelaksanaan pengalihan saham hasil Buy Back untuk periode 31 Desember 2025 Sebagai Berikut : Tanggal/Periode Transaksi 20 April 2025 Anggota Bursa Pelaksana (jika relevan) - Jumlah saham hasil buy back yang dijual/dialihkan 61.730.570 Harga rata-rata 0 Jumlah dana yang diperoleh 0 Kerugian dari Penjualan/Pengalihan (jika relevan) 0 Nama pihak yang membeli saham hasil Buy Back (jika relevan) - Dengan pelaksanaan pengalihan kembali saham Perseroan hasil Buy Back, maka akumulasi pengalihan kembali saham hasil Buy Back adalah sebagai berikut : Jumlah saham hasil Buy Back yang telah dijual/dialihkan 61.730.570 Jumlah dana yang diperoleh 0 Kerugian dari Penjualan/Pengalihan (jika relevan) 0 Jumlah Saham hasil buy back yang belum dialihkan 1.526.862.930 Informasi Lain Jumlah saham hasil buyback yang belum dialihkan sejumlah 1.526.862.930 saham adalah berdasarkan buyback yang dilakukan hingga 31 Desember 2025. Demikian untuk diketahui. Hormat Kami, Kalbe Farma Tbk Maria Teresa Fabiola Corporate Secretary Kalbe Farma Tbk
Page 2
Nama Pengirim Maria Teresa Fabiola
Jabatan Corporate Secretary
Tanggal dan Waktu 15-01-2026
Lampiran 1. KLBF - Perkembangan Pengalihan Saham Des 2025.pdf
Dokumen ini merupakan dokumen resmi Kalbe Farma Tbk yang tidak memerlukan tanda tangan karena dihasilkan
secara elektronik oleh sistem pelaporan elektronik. Kalbe Farma Tbk bertanggung jawab penuh atas informasi yang
tertera didalam dokumen ini.
Page 3
Go To Indonesian Page Letter / Announcement No. 005/CSEC-KF/I-2026 Issuer Name Kalbe Farma Tbk Issuer Code KLBF Attachment 1 Subject Report of Shares Transfer From Shares Buy Back Report of Transfer of Shares Buy Back The Company reported the execution of Buy Back for the period 31 December 2025 as follows : Date/Transaction Period 20 April 2025 Exchange Member (if relevant) - Number shares of buy back sold/transferred 61.730.570 Average sales / transfer price 0 Amount of fund raised 0 Loss on sale / transfer (if relevant) 0 Buyers name of shares buy back - With the execution of transfer shares buy back, the accumulation of the transfer of shares Buyback results as follows: The number of shares Buyback that have been sold / transferred 61.730.570 Amount of fund raised 0 Loss on sale / transfer (if relevant) 0 Remaining shares buy back 1.526.862.930 Other Information: The number of shares resulting from the buyback that have not been transferred is 1,526,862,930 shares, based on the buyback carried out until December 31, 2025. Thus to be informed accordingly. Respectfully, Kalbe Farma Tbk Maria Teresa Fabiola Corporate Secretary Kalbe Farma Tbk
Page 4
Sender Name Maria Teresa Fabiola
Function Corporate Secretary
Date and Time 15-01-2026
Attachment
This is an official document of Kalbe Farma Tbk that does not require a signature as it was generated electronically
by the electronic reporting system. Kalbe Farma Tbk is fully responsible for the information contained within this
document.
Names mentioned 2 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Maria Teresa Fabiola
· Corporate Secretary
p.1 ×3
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.